Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: β-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer’s disease and predicts cerebral amyloidosis

Fig. 2

Plasma Aβ concentrations in different diagnostic groups. In the current nEV study, 180 subjects (81 Aβ− NCs, 45 Aβ+ NCs, 34 aMCI, and 20 ADD individuals) had previously undergone plasma Aβ40 (A) and Aβ42 (B) quantification. C The ratio of Aβ42 to Aβ40 among the different diagnostic groups. Statistical analysis was conducted using the Kruskal–Wallis H test, followed by multiple post hoc comparisons (adjusted p value). Comparisons among groups: *p < 0.05; ns, > 0.05. Furthermore, a correlation analysis was performed between the Aβ42 to Aβ40 ratio and AV45 SUVR among the different groups (D). The correlation coefficients and p values are listed. Aβ, β-amyloid; NCs, cognitively normal controls; aMCI, amnestic mild cognitive impairment; ADD, Alzheimer’s disease dementia; nEV, neuronal-derived extracellular vesicle; AV45, [18F]florbetapir; SUVR, standardized uptake value ratio

Back to article page